Testing for carcinogenic or high-risk human papillomavirus (HPV) DNA has proven utility in cervical cancer screening and in many aspects of clinical management for cervical cancer prevention. However, inappropriate testing increases costs without benefit and potentially results in over-treatment of
โฆ LIBER โฆ
Commentary on: Statement on HPV DNA test utilization
โ Scribed by J. Thomas Cox; Ann T. Moriarty; Philip E. Castle
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 59 KB
- Volume
- 37
- Category
- Article
- ISSN
- 8755-1039
- DOI
- 10.1002/dc.21098
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Statement on HPV DNA test utilization
โ
Diane Solomon; Jacalyn L. Papillo; Diane D. Davey
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 96 KB
Statement on human papillomavirus DNA te
โ
Diane Solomon; Jacalyn L. Papillo; Diane D. Davey
๐
Article
๐
2009
๐
Wiley (John Wiley & Sons)
๐
English
โ 142 KB
This statement summarizes the expanded role of human papillomavirus (HPV) testing in the screening and management of cervical cancer. It also highlights circumstances in which HPV testing is not appropriate and may lead to overtreatment.
Poetic commentary on recombinant-DNA con
โ
Karp, Laurence E.
๐
Article
๐
1981
๐
John Wiley and Sons
๐
English
โ 140 KB
Impact of HPV testing, HPV vaccine devel
โ
Eltoum, Isam A. ;Roberson, Janie
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 279 KB
Statement validity analysis: An art or a
โ
Graham M. Davies
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 219 KB
Attitudes on DNA ancestry tests
โ
Jennifer K. Wagner; Kenneth M. Weiss
๐
Article
๐
2011
๐
Springer
๐
English
โ 544 KB